Skip to content
Research Article Open access CC BY 4.0

COVID 19 Omicron: The Origin, Presentation, Diagnosis, Prevention and Control

Abdulwasiu Oladele Hassan, Emmanuel Ifeanyi Obeagu, David Toluwani Ajayi, Adeyemo Abolaji Tolulope, Chinelo Chioma Madekwe, Chika Chizitelu Madekwe, Justina N. Ikpenwa, Sarah Nakyeyune

Asian Journal of Research in Infectious Diseases · pp. 25–33 · Published 3 Sep 2022

10.9734/ajrid/2022/v11i130303

Abstract

Coronaviruses have become a global health threat over the past two decades as their geographical spread has accelerated. Coronavirus disease 2019, also known as COVID-19, is the severe acute respiratory syndrome coronavirus 2 The epidemic caused by (SARS-CoV-2). The first known case was confirmed in Wuhan, China in December 2019, where he has caused two pandemics in the past. Severe acute respiratory syndrome and Middle East respiratory syndrome are followed by the current COVID-19 outbreak in China. The virus originates from a zoonotic source and is spread by direct and contact transmission. Symptoms range from fever to cough, muscle aches to severe respiratory failure. Diagnosis is confirmed by reverse transcriptase-PCR. Treatment of COVID-19 consists primarily of supportive care and mechanical ventilation in critical cases. Prevention strategies, along with successful disease isolation and community containment, play an important role in reducing the spread of the virus among the public. A vaccine has been developed to clear the virus from its host, but it is not yet known whether the vaccine works against the virus's newest subspecies, the Omicron subspecies. This review summarizes the most recent research advances in structure, epidemiology, and etiology. We also focused on mutational patterns, an important feature of viral virology, and examined existing variants, especially its omicron variant. The clinical features of COVID-19, current treatments, and scientific advances to combat the epidemic novel coronavirus were discussed.

Novel coronavirus severe acute respiratory syndrome diagnosis omicron

Cited by 3

Impacts of COVID-19 on hemostasis: coagulation abnormalities and management perspectives

Emmanuel Ifeanyi Obeagu, Muhammad Tukur, Kingsley Akaba · Annals of Medicine & Surgery · 2024

Therapeutic Potential of Neutralizing Monoclonal Antibodies (nMAbs) against SARS-CoV-2 Omicron Variant

Pijus Parua, Somnath Ghosh, Koushik Jana · Current Pharmaceutical Design · 2025

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

3

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.